Perrigo (NYSE:PRGO) Stock Price Up 4.5% – Time to Buy?

Perrigo Company plc (NYSE:PRGO) was up 4.5% during mid-day trading on Wednesday. The stock traded as high as $15.92 and last traded at $16.0660. Approximately 1,196,527 shares traded hands during mid-day trading, a decline of 61% from the average session volume of 3,066,198 shares. The stock had previously closed at $15.37.

Analyst Ratings Changes

A number of equities analysts recently weighed in on PRGO shares. Weiss Ratings upgraded shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. Wall Street Zen downgraded Perrigo from a “strong-buy” rating to a “buy” rating in a report on Sunday, September 27th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $19.33.

Perrigo Price Performance

The firm has a fifty day moving average price of $14.07 and a two-hundred day moving average price of $11.94. The stock has a market capitalization of $2.20 billion, a P/E ratio of -1.27, a PEG ratio of 1.77 and a beta of 0.69. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.32 and a current ratio of 2.32.

Perrigo (NYSE:PRGO) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.11. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the previous year, the company earned ($0.06) EPS. The firm’s revenue for the quarter was down 3.1% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, analysts expect that Perrigo Company plc will post 2.18 EPS for the current fiscal year.

Perrigo Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Friday, August 28th were issued a dividend of $0.29 per share. The ex-dividend date was Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a yield of 7.3%. Perrigo’s payout ratio is presently -9.27%.

Institutional Trading of Perrigo

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Sound Income Strategies LLC lifted its holdings in shares of Perrigo by 3.9% in the 3rd quarter. Sound Income Strategies LLC now owns 1,615,467 shares of the company’s stock worth $23,424,000 after buying an additional 60,838 shares during the period. Bank of America Corp DE increased its stake in shares of Perrigo by 25.5% during the first quarter. Bank of America Corp DE now owns 1,568,598 shares of the company’s stock valued at $16,847,000 after buying an additional 318,248 shares during the period. First Trust Advisors LP increased its stake in shares of Perrigo by 125.5% during the first quarter. First Trust Advisors LP now owns 1,496,244 shares of the company’s stock valued at $16,070,000 after buying an additional 832,686 shares during the period. Gamco Investors INC. ET AL raised its holdings in shares of Perrigo by 29.7% in the first quarter. Gamco Investors INC. ET AL now owns 1,397,866 shares of the company’s stock valued at $15,013,000 after acquiring an additional 320,081 shares in the last quarter. Finally, O Keefe Stevens Advisory Inc. raised its holdings in shares of Perrigo by 9.6% in the third quarter. O Keefe Stevens Advisory Inc. now owns 915,885 shares of the company’s stock valued at $13,518,000 after acquiring an additional 80,230 shares in the last quarter. Hedge funds and other institutional investors own 95.91% of the company’s stock.

About Perrigo

Perrigo Company plc (NYSE: PRGO) is a global consumer self-care company that develops, manufactures and sells over-the-counter (OTC) health and wellness products. Its portfolio includes products for pain relief, allergy and cold relief, digestive health, sleep support, skin care, women’s health and oral care. Perrigo supplies both its own brands and retailer-owned store brands.

The company markets products under a range of brand names, including Compeed, ACO, ellaOne and other regional brands, while also producing private-label alternatives to widely used consumer health products.